The Food and Drug Administration last week approved the use of Trinity Biotech's Uni-Gold Recombigen HIV test for use in about 200,000 clinics and doctors' offices in the United States. The FDA approved the test for use in hospitals in December 2003. The test can detect HIV antibodies in whole blood, serum, or plasma in about 10 minutes. The FDA issued a Clinical Laboratory Improvements Amendments waiver allowing its use in nonhospital settings for whole blood samples, including finger-stick samples.
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Stay up to date with the latest in LGBTQ+ news with The Advocate’s email newsletter, in your inbox five days a week.
@ 2026 Equal Entertainment LLC.
All rights reserved
All rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
The Latest
Support Independent Journalism
LGBTQ+ stories deserve to betold.
Your membership powers The Advocate's original reporting—stories that inform, protect, and celebrate our community.
Become a Member
FOR AS LITTLE AS $5. CANCEL ANYTIME.
More For You
Most Popular
@ 2026 Equal Entertainment LLC. All Rights reserved















